je.st
news
Tag: cervical
New HPV vaccine from Merck strengthens cervical cancer protection
2014-12-10 22:43:17| Biotech - Topix.net
The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.
Tags: protection
cancer
vaccine
cervical
Experimental Cervical Cancer Vaccine Looks Promising in Trial
2014-10-02 06:35:36| Biotech - Topix.net
An experimental vaccine meant to protect against nine types of human papillomavirus could prevent 90 percent of all cervical cancers, a new study suggests. Researchers examined data from more than 2,500 women with precancerous cervical lesions and found that nearly all were caused by the nine types of HPV targeted by the vaccine being developed by Merck and Co.
Tags: trial
cancer
experimental
promising
Comparison of Swine AI Procedures Between Traditional Cervical Catheters and a New Model of Hydraulic IUI under Field Conditions
2014-04-17 02:00:00| ThePigSite - Industry News
An experiment in Thailand reveals better results for artificial insemination of sows using a new catheter from Absolute Swine Insemination Co. than a conventional foam-tipped catheter; more sows were bred by seven days using two doses with the new catheter than with three doses using the foam device.
Tags: of
under
conditions
field
Mercks Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study
2013-11-04 13:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Immunogenicity non-inferior to GARDASIL for original four HPV types Merck expects to file Biologics License Application with U.S. FDA in 2013 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that in the pivotal Phase III efficacy study, its investigational 9-valent HPV vaccine (V503) prevented approximately 97 percent of cervical, vaginal and vulvar pre-cancers caused by HPV types 31, 33, 45, 52, and 58. Language: English Contact: Media:Pamela Eisele, 908-423-5042orImraan Munshi, 215-652-0059orInvestor:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
additional
study
iii
Sites : [1] [2]